期刊论文详细信息
American Journal of Cancer Research
High visfatin expression predicts poor prognosis of upper tract urothelial carcinoma patients
Hung-Lung Ke1 
关键词: Nampt/PBEF/visfatin;    upper tract urothelial carcinoma;    immunohistochemistry;    prognosis;    survival;   
DOI  :  
学科分类:肿瘤学
来源: e-Century Publishing Corporation
PDF
【 摘 要 】

Visfatin, a newly discovered adipocytokine, is a pro-inflammatory cytokine. This study aimed to evaluate the predictive value of visfatin on prognosis of patients with upper tract urothelial carcinoma. One-hundred and five patients (median age=64, range=24-84 years) were included in this study. Visfatin expression in upper tract urothelial carcinoma tissues was analyzed by immunohistochemistry. Visfatin expression was correlated with clinicopathologic variables using the χ2 test. The prognostic value of visfatin for recurrence-free and cancer-specific survival was evaluated by Kaplan-Meier estimates, and the significance of differences between curves was evaluated by the log-rank test. Cox regression model was also used to evaluate the hazard ratios of visfatin on survival. High visfatin expression in upper tract urothelial carcinoma tissues was significantly correlated with tumor stage (P=0.001), grade (P=0.007) and p53 expression (P=0.07). High visfatin expression was associated with poor recurrence-free and cancer-specific survival. Cox regression analysis also revealed that visfatin is an independent predictor of recurrence-free (HR=3.22, P=0.009) and cancer-specific survival (HR=5.74, P=0.023). Our findings indicated that higher visfatin expression is a potential biomarker to predict patient survival. Further study is necessary to investigate the role of visfatin in the carcinogenesis of upper tract urothelial carcinoma.

【 授权许可】

CC BY-NC   

【 预 览 】
附件列表
Files Size Format View
RO201904036417300ZK.pdf 672KB PDF download
  文献评价指标  
  下载次数:17次 浏览次数:1次